The enterotoxin from Vibrio cholerae is selectively concentrated from cell-free culture supernatant by co-precipitation with hexametaphosphate and is further purified by adsorption on aluminum hydroxide powder. 
spectra characteristic of pure protein; and (v) overall yields on the order of 50%, irrespective of purification scale. Such preparations, however, have been shown to contain trace amount$ of somatic antigen when they are intensively tested either for their ability to elevate serum vibriocidal antibody titers in immunized rabbits or for their ability to increase resistance of immunized mice to live vibrio challenge. In the latter test system, the level of residual somatic antigen per 50 jig of toxin (toxoid) antigen generally did not exceed 0.025% of the Division of Biological Standards reference vaccine, V. cholerae Inaba Methods for elimination of this small amount of somatic antigen have been investigated and are discussed. The particular combination of purification steps which are presently described have been easily and reproducibly applied on a production scale to prepare gram amdunts of toxin with a high degree of purity, even under a variety of initial conditions. At present, a convincing body of evidence supports the view that the symptoms of clinical cholera are caused by an enterotoxin secreted into the gut by proliferating Vibrio cholerae (2, 18) . On the basis of this view and because conventional bacterial vaccines do not provide adequate long-term protection (1, 24) , interest has been aroused in determining whether antitoxic immunity alone can provide effective protection against the clinical manifestations of cholera.
The availability of V. cholerae strains, most notably Inaba 569B, that can produce toxin in vitro, together with reliable methods for its production (8, 13, 20) , purification (12, 21, 22) , and routine assay (3) (4) (5) , have greatly advanced the possibility of testing this hypothesis.
Further, the development of experimental cholera models (2, 18) has made it possible to study the efficacy of antitoxic immunity in preventing or controlling symptoms of the disease. In the canine model, for example, parenteral immunization with crude cholera toxin, which stimulates the production of both antibacterial and antitoxic antibody, protected dogs against subsequent intraintestinal challenge with viable V. cholerae (6) . This protection correlated more significantly with serum antitoxin titers than with serum vibriocidal titers (6) . More recently, dogs immunized parenterally with pure cholera toxin (plus Freund adjuvant) exhibited elevated serum antitoxin titers and were protected against challenge with viable V. cholerae for at least 10 months (19) . In the same study, parenteral immunization with formalinized toxoid (without adjuvant), although resulting in lower antitoxin titers, gave rise to significant protection which endured for a minimum of 5 months (19) . This result suggested that antitoxic antibody elicited by chemically detoxified toxin (toxoid) may also correlate with protection in experimental canine cholera. It remains to be determined, however, whether or not appropriate parenteral immunization with a suitable cholera toxoid will provide effective protection in experimental human cholera, and such studies have already been initiated (R. B. Hornick, personal communication).
To determine unambiguously whether antitoxic antibodies alone can provide effective and prolonged protection in the field, a pure toxin, possessing little or no ability to induce vibriocidal antibodies, is required. To produce purified toxin in sufficient quantity for potential use as a prophylactic against cholera, a simple, large-scale purification scheme has been developed. The details of this method are described in this report. The problems surrounding the preparation of a stable, antigenic toxoid are the subject of a subsequent communication. MATERIALS Preparation of antisera. Antiserum was prepared in goats. Toxin preparations were mixed 1:2 with Amphogel (Wyeth Laboratories, Inc.), and 2.5 ml of the mixture was injected intramuscularly into each of four legs. Boosters were given 2 and 4 weeks after the initial injection by using 1.25 ml of the mixture in each of four legs. The goats were bled 2 weeks after the last booster injection. Antisera against two preparations of toxin were obtained. One preparation, containing approximately 3,000 Lb doses/ml, was a 10 x Amicon PM-10 concentrate of the antigens in crude cell-free culture fluid. The second preparation, containing approximately 1,300 Lb doses/ml, was concentrated from cell-free supernatant by precipitation with ammonium sulfate (60% saturation), adsorbed onto and eluted from aluminum hydroxide, and filtered through an Amicon XM-100 membrane. The latter preparation contained some sedimentable somatic antigen as determined retrospectively by analysis of both the immune sera and the antigen preparation. Antiserum to the first preparation was labeled Wyeth goat no. 1 antitoxin, and antiserum to the second preparation was labeled Wyeth goat no. 2 antitoxin.
Measurement of toxin potency. Toxin content of preparations was estimated by the limit of bluing method in rabbit skin as described by Craig (3, 4) (4) . One Lb is that amount of toxin which, in the presence of 1 AU/ml, gives a 4-mm bluing lesion in rabbit skin (4). Unless otherwise specified, all Lb titrations were carried out at the Lb/20 level, and potencies are expressed in Lb doses per milliliter.
Toxoid units. To quantify preparations of inactivated toxin (toxoid), toxoid units (TU), a measure of antitoxin combining power, were determined according to a method devised by Craig (4; personal communication). Based on the ability of toxoid to combine with antitoxin in vitro, the assay measures the apparent decrease in neutralizing capacity of a known amount of antitoxin after it has been incubated with toxoid. A series of tubes containing equal volumes of antitoxin (2 AU/ml) and an appropriate dilution of toxoid were incubated at 37 C for 30 min. Another series of tubes containing equal volumes of antitoxin (2 AU/ml) and buffer were incubated under the same conditions. After incubation, an equal volume of serial 0.15 log dilutions of toxin were added to each series of tubes, and the assay was carried out in a manner identical to the Lb assay described above. Immunoelectrophoresis was performed with a Shandon electrophoresis apparatus according to the procedure described by Finkelstein and LoSpalluto (12) with the exceptions that: (i) electrophoresis was performed for 2 h at 4 C; and (ii) polyvalent antiserum (Wyeth goat no. 1 antitoxin) was used for development of the immunoprecipitin pattern. Samples were concentrated to approximately 10 mg/ml by dialysis against Ficoll (Pharmacia, Piscataway, N. J.) before electrophoresis.
Acrylamide gel electrophoresis. Acrylamide gel electrophoresis was performed at pH 9.3 by using the standard two-gel system described by Ornstein (17) and Davis (7), and by using Canalco equipment (Canal Industrial Corp., Rockville, Md.). Before electrophoresis, samples were dialyzed against 0.025 M tris(hydroxymethyl)aminomethane, 0.19 M glycine, pH 8.3 . Between 100 and 200 gg of protein in 0.2 to 0.3 ml was layered on top of the spacer gel with a drop of glycerol. Current was 1 mA per gel until the tracking dye entered the separating gel; then the current was increased to 2 mA per gel for the remainder of the run. In some instances, electrophoresis was allowed to proceed 30 min beyond the clearance of the tracking dye from the gel.
Electron microscopy. representative large-scale preparation. In the first step of the procedure, toxin was concenr trated from cell-free culture filtrate by coprecipitation with sodium hexametaphosphate at pH 4.6. Figure 1 shows the distribution of precipitating species as a function of pH in the presence and absence of metaphosphate. The addition of metaphosphate to the culture filtrate enhanced precipitation throughout the pH gradient and partitioned the precipitating species into three distinguishable zones. Activity assays and immunodiffusion tests showed that toxin precipitated in the first zone between pH 5.4 and 4.6. When toxin was concentrated by the metaphosphate procedure, increases in specific activity on the order of 15-fold or greater and recoveries of 90% or more were reproducibly obtained in four consecutive large-scale preparations.
In the second step of the procedure, toxin was further purified by adsorption onto, and elution from, aluminum hydroxide powder. Adsorption was pH dependent, with maximal binding of toxin occurring at or near pH 5.6. Elution appeared to be independent of the buffer system employed as long as the pH was alkaline. In this procedure, toxin was eluted from the adsorbent with 0.2 M ammonium bicarbonate, pH 8.0.
Under conditions of maximal binding, toxin recoveries were governed by the relative concentration of toxin and adsorbent. Figure 2 shows the dependence of recovery on percent concentration of adsorbent suspension for the case in which the amount of toxin exceeded the adsorption capacity of the powder. When conditions were such that the ratio of total Lb units per gram of adsorbent was on the order of 10', toxin recoveries ranging from 60 to 72% were reproducibly obtained in four consecutive large-scale Conditions for sedimenting optimal amounts of somatic antigen were determined by centrifuging samples of crude culture filtrate (from which all detectable toxin had been removed by metaphosphate precipitation) and determining by radial immunodiffusion the amount of somatic antigen sedimented as a function of time. For this purpose, antiserum specific for both this particular somatic antigen and toxin (Wyeth goat no. 2 antitoxin) was employed. Since toxin had been removed from the culture filtrate, only precipitin rings due to the interaction of somatic antigen with its antibody were observed. The amount of somatic antigen which could be sedimented reached a maximum after centrifugation at 78,410 x g for 6 h in a Spinco 30 rotor (Fig. 3) . In scaling up the procedure to accommodate larger volumes, equivalent results were obtained when the Spinco 21 rotor was substituted for the 30 rotor and sedimentation was performed at 44,330 x g for a minimum of 16 h. To achieve additional purity, aluminum hydroxide-purified toxin preparations were lyophilized, dissolved in a reduced volume of buffer, treated with activated carbon, and centrifuged under the conditions described above. Lyophilization was employed to reduce volumes for centrifugation but, more importantly, because residual somatic antigen tended to become insoluble after lyophilization. Activated carbon removed variable (from lot to lot) amounts of yellow-brown contaminant(s), which became apparent only after concentration. After carbon treatment, toxin preparations were generally water-clear and they exhibited ultraviolet spectra characteristic of pure protein (Fig. 4 and Table 1 ).
Finally, purified toxin was filtered aseptically through a membrane filter (0.22 um, Millipore Corp.) and stored at 4 C without loss in activity for periods of at least 6 months. Overall toxin yields on the order of 50% or more, and specific activities on the order of 22 Lb doses/ Immunodiffusion and immunoelectrophoresis. Ouchterlony-type double diffusion was used as a qualitative method for monitoring purification. Figure 5 identified as toxin and which could be monitored quantitatively by radial immunodiffusion throughout subsequent steps of the purification procedure. Purified toxin preparations, containing on the order of 1 mg of toxin per ml, continued to exhibit a single immunoprecipitin line when they were diffused against the aforementioned polyvalent antiserum. The somatic antigen nearest to the antigen wells in the cell-free culture filtrate and metaphosphate supernatant fractions (see Fig. 5 ), respectively, was identical to the antigen which was subsequently removed from toxin preparations by sedimentation.
The discovery and isolation by Finkelstein and LoSpalluto (12, 13) of a degradation product of toxin (11), which they named choleragenoid and which they showed was electrophoretically distinguishable but immunologically indistinguishable from toxin (12) , prompted an investigation of its possible presence in preparations of toxin purified by the present procedure. Immunoelectrophoretic analysis comparing two representative toxin preparations with a preparation of choleragenoid provided by R. A. Finkelstein revealed that toxin purified by the present method does not contain significant amounts, if any, of choleragenoid (Fig. 6 ). Polyvalent antiserum (Wyeth goat no. 1 antitoxin) was used in the development of the immunoprecipitin pattern because Ouchterlony-type immunodiffusion tests had shown that choleragenoid and the toxin preparations exhibited a single, identical immunoprecipitin line when reacted against this antiserum.
Acrylamide gel electrophoresis. After electrophoresis and staining, toxin appeared as a broad, somewhat diffuse band which could be resolved into one major and one (or two) minor bands (Fig. 7) . The possibility that the minor band(s) were contaminants was dismissed when the major band, after excision from unstained gels, exhibited the same electrophoretic pattern (as before) upon re-electrophoresis. In addition, when toxin was preincubated at 37 C in the presence of 0.035% ammonium persulfate (the catalyst for polymerization of the separating gel), a change in the distribution of proteins from the major to the minor species was observed. Whether or not the minor bands occurred exclusively as a result of electrophoresis (because of oxidation due to excess persulfate) or occurred during production and/or purification as well, has not been determined.
Efforts to distinguish between the major and minor species either by immunological techniques or by electron microscopy proved unsuccessful. When unstained gels were sliced into 2-mm disks and the disks were placed on agar containing antitoxin, immunoprecipitin rings were observed surrounding gel slices from regions corresponding to both the major and minor species. Similarly, when protein was eluted from such slices and assayed for activity, a symmetrical profile (of activity) with a shoulder in the region occupied by the minor bands was observed. Further, electron microscopy of excised fractions levealed similar particle types in the eluants associated with both the major and minor species.
Electron microscopy. Examinati6n of a representative toxin preparation by electron microscopy revealed a quasi-crystalline array of uniform, closely packed particles (Fig. 8) As determined by the microtiter vibriocidal assay, geometric mean serum titers from groups of rabbits immunized with representative Formalin toxoids ranged from 10 to 40 vibriocidal antibody units per ml 4 weeks after primary in- cidal titers rose 2 weeks after booster inoculation, achieving levels approximately one-third of the NIH reference (convalescent) antiserum; but they declined towards the titers cited above within several weeks (Table 3) . However, rabbits twice immunized with 100 pg of glutaraldehyde toxoid (with a 6-week interval between inoculations) exhibited vibriocidal titers which were significantly reduced relative to titers elicited by Formalin toxoid (Table 4) . Even when this toxoid was administered with adjuvant (Table 4) , post-booster titers were approximately 100-fold less than the NIH reference antiserum.
DISCUSSION
An effective and comparatively simple method for the large-scale production of purified cholera toxin has been developed. Starting with cell-free culture filtrates, the method relies entirely upon batch procedures, each of which results in a reduction in volume and a concomitant increase in specific activity. The method has proven reliable regardless of whether the initial volume of culture filtrate was 1 or 250 liters.
The metaphosphate precipitation technique employed in the first step of the procedure was developed some years ago by one of us (H. Tint, U.S. patent 2, 772, 201, 1956 ) for the concentration and purification of tetanus and diphtheria toxoids. Involving the formation of complexes between the phosphate polymers and proteins and the subsequent precipitation of these complexus at their respective isoelectric pHs, the method was designed to purify as well as concentrate. In its original application, all of the protein complexes having an isoelectric pH equal to or higher than that of the desired protein were precipitated together and dis- VOL. 9, 1974 solved in an appropriate buffer, and the desired protein was then fractionated according to its solubility characteristics. In this particular system, the toxin-metaphosphate complexes were among the first species to precipitate as the pH was lowered to 4.6, so that concentration as well as a substantial increase in specific activity was accomplished in a single step. It may be of interest that the somatic antigens remaining in the metaphosphate supernatant fraction (see Fig. 5 ) could also be concentrated and purified by selective precipitation below pH 4.6. In the purification of toxin by aluminum hydroxide adsorption, the powder form of the adsorbent was used exclusively. This was because the powder form proved to have greater selectivity for toxin than did aluminum hydroxide gels such as those used by Spyrides and Feeley (22) in their original observations. The one disadvantage of the powder adsorbent was that approximately 2 g of adsorbent was used to purify as little as 1 mg of toxin. A possible explanation for this observation may be that other ions in the medium are competing with toxin for binding sites on the adsorbent.
Although the specific activity of toxin preparations was relatively high after aluminum hydroxide purification, subsequent lyophilization and centrifugation consistently resulted in a substantial reduction in the amount of residual somatic antigen. In a few instances where residual somatic antigen levels were higher than usual (as, for example, when the starting material was 48-h culture filtrate), recycling the purified toxin preparation through the lyophilization and centrifugation steps resulted in removal of approximately 70% of the residual somatic antigen. Also, in cases where the amount of pigment contamination was greater than usual, a repetition of the carbon treatment resulted in the complete removal of these contaminants.
On the basis of mass, the amount of residual somatic antigen recovered by sedimentation was small. Although no detailed chemical analyses were performed, this antigen exhibited characteristics similar to the proteinlipopolysaccharide complex isolated from Inaba serotypes by Watanabe et al. (23) , since it could be described as a polydisperse, fine suspension which tended to become insoluble upon freezing and lyophilization. The observation that toxin preparations continued to exhibit very low levels of somatic antigen after lyophilization and centrifugation suggested that, even when present in trace amounts, this antigen was either highly immunogenic or its immunogenicity was greatly enhanced in the presence of toxin or toxoid.
In terms of specific activity (of toxin), the preparations described here compare favorably with other purified preparations described by the most often cited investigators, Finkelstein and LoSpalluto (12) and Richardson et al. (21) , in that the amount of toxin required to produce a 7-mm bluing lesion in rabbit skin is on the order of 0.1 to 0.5 ng. With regard to content of somatic antigen, it is more difficult to compare our material with that of other investigators because either insufficient data are available or different methods of analysis have been employed.
Richardson et al. (21) reported the presence of "low but consistent vibriocidal antibody titer rise" in rabbits immunized with some of their preparations, and Finkelstein and LoSpalluto employed an in vitro neutralization test (10) to demonstrate the absence of somatic antigen from their toxin preparations (13) . Recently, a group of rabbits immunized in this laboratory with 100 ,g of a Formalin toxoid prepared from a toxin preparation purified by R. A. Finkelstein (lot 1071; prepared under contract for the National Institute of Allergy and Infectious Diseases essentially according to procedures described in reference 12) showed no significant rise in serum vibriocidal antibody after primary and secondary immunizations.
Although the ultimate objective of this investigation was to develop a reliable production-scale method for the preparation of purified toxin (toxoid) with no ability to elicit vibriocidal antibody, the data clearly show that representative toxoid preparations stimulate low levels of vibriocidal antibody in mice and rabbits when they are suitably immunized with a higher than anticipated human dose (100 to 200 ug). The reason that glutaraldehyde toxoids elicited significantly less vibriocidal antibody than did Formalin toxoids is thought to be related more to the different stability characteristics of the toxoids (the subject of the subsequent manuscript) than to a direct effect of glutaraldehyde on somatic antigen.
In addition, it has been demonstrated that residual somatic antigen can be eliminated by molecular sieve chromatography (using Sephadex G-150, Sephadex G-200, or Bio-Gel A-5M gels) or, alternatively, by affinity chromatography (using purified vibriocidal antibody bound to Sepharose 4B); these techniques are presently being evaluated on a production scale.
Whether or not material of the quality presently achieved can be utilized to determine, unambiguously, the efficacy of antitoxic immunity in endemic areas is the subject of continuing investigation. Irrespective of the outcome of such investigations, this material should be useful in studying the protein chemistry and mechanism of action of cholera toxin in various biological systems. Ultimately, material of the quality presently described should, without further purification, be a suitable candidate for large-scale immunization, provided that antitoxic efficacy is established.
